Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Potent P2X 7 receptor antagonists: Tyrosyl derivatives synthesized using a sequential parallel synthetic approach

Potent P2X 7 receptor antagonists: Tyrosyl derivatives synthesized using a sequential parallel... Novel analogs of 1‐(N,O‐bis(5‐isoquinolinesulfonyl)‐N‐methyl‐L‐tyrosyl)‐4‐phenylpiperazine (KN‐62, 1) were synthesized and found to be potent antagonists in a functional assay, inhibition of ATP‐induced K+ efflux in HEK293 cells expressing recombinant human P2X7 receptors. Antagonism of murine P2X7 receptors was also observed. The analogs consisted of L‐tyrosine derivatives, of the general structure R1‐Tyr(OR2)‐piperazinyl‐R3, in which three positions were systematically varied in structure through facile acylation reactions. Each of the three positions was optimized in sequence through parallel synthesis alternating with biological evaluation, leading to the identification and optimization of potent P2X7 antagonists. The optimal groups at R1 were found to be large hydrophobic groups, linked to the ॅ‐amino position through carbamate, amide, or sulfonamide groups. The benzyloxycarbonyl (Cbz) group was preferred over most sulfonamides and other acyl groups examined, except for quinoline sulfonyl. At R2, an arylsulfonate ester was preferred, and the order of potency was p‐tolyl, p‐methoxyphenyl, phenyl > ॅ‐naphthyl, ॆ‐naphthyl. A benzoyl ester was of intermediate potency. Aliphatic esters and carbonate derivatives at the tyrosyl phenol were inactive, while a tyrosyl O‐benzyl ether was relatively potent. The most potent P2X7 receptor antagonists identified in this study contained Cbz at the R1 position, an aryl sulfonate at the R2 position, and various acyl groups at the R3 position. At R3, t‐butyloxycarbonyl‐ and benzoyl groups were preferred. The opening of the piperazinyl ring to an ethylene diamine moiety abolished antagonism. In concentration–response studies, a di‐isoquinolinyl, Boc derivative, 4 (MRS2306), displayed an IC50 value of 40 nM as an antagonist of P2X7 receptor‐mediated ion flux and was more potent than the reference compound 1. Nॅ‐Cbz, Boc‐piperazinyl derivatives, 11 (MRS2317), 22 (MRS2326), and 41 (MRS2409) were less potent than 1, with IC50 values of 200–300 nM. Drug Dev. Res. 54:75–87, 2001. © 2001 Wiley‐Liss, Inc. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Drug Development Research Wiley

Potent P2X 7 receptor antagonists: Tyrosyl derivatives synthesized using a sequential parallel synthetic approach

Loading next page...
 
/lp/wiley/potent-p2x-7-receptor-antagonists-tyrosyl-derivatives-synthesized-wUBINEfUCa

References (37)

Publisher
Wiley
Copyright
Copyright © 2001 Wiley‐Liss, Inc.
ISSN
0272-4391
eISSN
1098-2299
DOI
10.1002/ddr.1207
Publisher site
See Article on Publisher Site

Abstract

Novel analogs of 1‐(N,O‐bis(5‐isoquinolinesulfonyl)‐N‐methyl‐L‐tyrosyl)‐4‐phenylpiperazine (KN‐62, 1) were synthesized and found to be potent antagonists in a functional assay, inhibition of ATP‐induced K+ efflux in HEK293 cells expressing recombinant human P2X7 receptors. Antagonism of murine P2X7 receptors was also observed. The analogs consisted of L‐tyrosine derivatives, of the general structure R1‐Tyr(OR2)‐piperazinyl‐R3, in which three positions were systematically varied in structure through facile acylation reactions. Each of the three positions was optimized in sequence through parallel synthesis alternating with biological evaluation, leading to the identification and optimization of potent P2X7 antagonists. The optimal groups at R1 were found to be large hydrophobic groups, linked to the ॅ‐amino position through carbamate, amide, or sulfonamide groups. The benzyloxycarbonyl (Cbz) group was preferred over most sulfonamides and other acyl groups examined, except for quinoline sulfonyl. At R2, an arylsulfonate ester was preferred, and the order of potency was p‐tolyl, p‐methoxyphenyl, phenyl > ॅ‐naphthyl, ॆ‐naphthyl. A benzoyl ester was of intermediate potency. Aliphatic esters and carbonate derivatives at the tyrosyl phenol were inactive, while a tyrosyl O‐benzyl ether was relatively potent. The most potent P2X7 receptor antagonists identified in this study contained Cbz at the R1 position, an aryl sulfonate at the R2 position, and various acyl groups at the R3 position. At R3, t‐butyloxycarbonyl‐ and benzoyl groups were preferred. The opening of the piperazinyl ring to an ethylene diamine moiety abolished antagonism. In concentration–response studies, a di‐isoquinolinyl, Boc derivative, 4 (MRS2306), displayed an IC50 value of 40 nM as an antagonist of P2X7 receptor‐mediated ion flux and was more potent than the reference compound 1. Nॅ‐Cbz, Boc‐piperazinyl derivatives, 11 (MRS2317), 22 (MRS2326), and 41 (MRS2409) were less potent than 1, with IC50 values of 200–300 nM. Drug Dev. Res. 54:75–87, 2001. © 2001 Wiley‐Liss, Inc.

Journal

Drug Development ResearchWiley

Published: Oct 1, 2001

Keywords: ion channels; nucleotides; structure activity relationships; purines; isoquinolines; KN‐62

There are no references for this article.